Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...

Amanda Watson was diagnosed with breast cancer three weeks after having an emergency cesarean section to deliver her second son. Her test results showed she had one of the most aggressive forms ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZAtm (vimseltinib), a kinase ...

Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05, Human Interferon ?1b Inhalation Solution, a self-developed product by ...

One of Trump's initial orders, titled “Protecting The American People Against Invasion,” called for a dramatic surge in ...

1. The bill, titled the Doctors Know Best Act, was proposed in early January. It would prohibit any group health plans, insurance providers and federal healthcare programs from utilizing prior ...

Dallas, filed a bill this legislative session to prohibit insurance companies from requiring prior authorization before covering medications intended to prevent the ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

A federal appellate court has upheld the Drug Enforcement Administration’s denial of a Seattle doctor’s request to use ...

The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...

A team of specialists from Mudanjiang Cardiovascular Hospital perform surgery on a 10-year-old patient with heart disease ...

This feature is a deep dive into the challenges of defining and treating Difficult-to-Treat Rheumatoid Arthritis (D2T-RA).